In contrast, CAR‐T cells infused in hiNeuroSRANTES‐IL‐15‐treated mice markedly inhibited tumor growth, reducing tumor volumes 2538‐fold by Day 10 with most tumors decreasing below the level of detection. The gene discussed is IL15; the disease is neoplasm.